SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about voting results of EGM

19 Jan 2024 Evaluate

Fredun Pharmaceuticals has informed that it enclosed the Voting Results of Extra Ordinary General of the company as required under Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements), 2015.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

2096.85 52.95 (2.59%)
22-Apr-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.40
Dr. Reddys Lab 1220.35
Cipla 1234.20
Zydus Lifesciences 930.20
Lupin 2305.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×